SEC Filing Summary: Stellar Biotechnologies, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by Stellar Biotechnologies, Inc. on May 25, 2016. The registrant is incorporated in British Columbia, Canada, with principal executive offices in Port Hueneme, California. The filing reports a corporate recognition event rather than financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
There are no material financial changes reported in this document. The sole material event is the Company's recognition as a 2016 California Small Business of the Year, announced via a press release on May 25, 2016.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, risk factors, or discussion of contingencies. The document solely references the award ceremony held at the state capitol in Sacramento, California.
Investor Verification Checklist
- Verify the Company's name is Stellar Biotechnologies, Inc., noting the discrepancy with the metadata field "Edesa Biotech, Inc."
- Confirm the details of the "2016 California Small Business of the Year" award via the attached press release (Exhibit 99.1).
- Review the Company's most recent 10-K or 10-Q filings for actual financial performance data, as this 8-K contains none.